398 related articles for article (PubMed ID: 31256135)
21. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model.
Shi L; Zhang Z; Li L; Hölscher C
Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971
[TBL] [Abstract][Full Text] [Related]
22. Cognitive-Enhancing Effects of a Polyphenols-Rich Extract from Fruits without Changes in Neuropathology in an Animal Model of Alzheimer's Disease.
Dal-Pan A; Dudonné S; Bourassa P; Bourdoulous M; Tremblay C; Desjardins Y; Calon F;
J Alzheimers Dis; 2017; 55(1):115-135. PubMed ID: 27662290
[TBL] [Abstract][Full Text] [Related]
23. SGLT2 and DPP4 inhibitors improve Alzheimer's disease-like pathology and cognitive function through distinct mechanisms in a T2D-AD mouse model.
Sim AY; Choi DH; Kim JY; Kim ER; Goh AR; Lee YH; Lee JE
Biomed Pharmacother; 2023 Dec; 168():115755. PubMed ID: 37871560
[TBL] [Abstract][Full Text] [Related]
24. Brain GLP-1/IGF-1 Signaling and Autophagy Mediate Exendin-4 Protection Against Apoptosis in Type 2 Diabetic Rats.
Candeias E; Sebastião I; Cardoso S; Carvalho C; Santos MS; Oliveira CR; Moreira PI; Duarte AI
Mol Neurobiol; 2018 May; 55(5):4030-4050. PubMed ID: 28573460
[TBL] [Abstract][Full Text] [Related]
25. The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease.
Amidfar M; de Oliveira J; Kucharska E; Budni J; Kim YK
Life Sci; 2020 Sep; 257():118020. PubMed ID: 32603820
[TBL] [Abstract][Full Text] [Related]
26. Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis.
Wu Z; Chen C; Kang SS; Liu X; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140411
[TBL] [Abstract][Full Text] [Related]
27. Sitagliptin protects the cognition function of the Alzheimer's disease mice through activating glucagon-like peptide-1 and BDNF-TrkB signalings.
Dong Q; Teng SW; Wang Y; Qin F; Li Y; Ai LL; Yu H
Neurosci Lett; 2019 Mar; 696():184-190. PubMed ID: 30597232
[TBL] [Abstract][Full Text] [Related]
28. Beneficial Effects of Fingolimod in Alzheimer's Disease: Molecular Mechanisms and Therapeutic Potential.
Angelopoulou E; Piperi C
Neuromolecular Med; 2019 Sep; 21(3):227-238. PubMed ID: 31313064
[TBL] [Abstract][Full Text] [Related]
29. The GLP-1 receptor agonist exenatide ameliorates neuroinflammation, locomotor activity, and anxiety-like behavior in mice with diet-induced obesity through the modulation of microglial M2 polarization and downregulation of SR-A4.
Lin MH; Cheng PC; Hsiao PJ; Chen SC; Hung CH; Kuo CH; Huang SK; Clair Chiou HY
Int Immunopharmacol; 2023 Feb; 115():109653. PubMed ID: 36587502
[TBL] [Abstract][Full Text] [Related]
30. Donepezil improves the cognitive impairment in a tree shrew model of Alzheimer's disease induced by amyloid-β
Zheng H; Niu S; Zhao H; Li S; Jiao J
Metab Brain Dis; 2018 Dec; 33(6):1961-1974. PubMed ID: 30105614
[TBL] [Abstract][Full Text] [Related]
31. Neurotrophic Treatment Initiated During Early Postnatal Development Prevents the Alzheimer-Like Behavior and Synaptic Dysfunction.
Wei W; Liu Y; Dai CL; Baazaoui N; Tung YC; Liu F; Iqbal K
J Alzheimers Dis; 2021; 82(2):631-646. PubMed ID: 34057082
[TBL] [Abstract][Full Text] [Related]
32. Intranasal delivery of BDNF rescues memory deficits in AD11 mice and reduces brain microgliosis.
Braschi C; Capsoni S; Narducci R; Poli A; Sansevero G; Brandi R; Maffei L; Cattaneo A; Berardi N
Aging Clin Exp Res; 2021 May; 33(5):1223-1238. PubMed ID: 32676979
[TBL] [Abstract][Full Text] [Related]
33. Effective nose-to-brain delivery of exendin-4 via coadministration with cell-penetrating peptides for improving progressive cognitive dysfunction.
Kamei N; Okada N; Ikeda T; Choi H; Fujiwara Y; Okumura H; Takeda-Morishita M
Sci Rep; 2018 Dec; 8(1):17641. PubMed ID: 30518944
[TBL] [Abstract][Full Text] [Related]
34. A dual GLP-1 and Gcg receptor agonist rescues spatial memory and synaptic plasticity in APP/PS1 transgenic mice.
Wang ZJ; Han YF; Zhao F; Yang GZ; Yuan L; Cai HY; Yang JT; Holscher C; Qi JS; Wu MN
Horm Behav; 2020 Feb; 118():104640. PubMed ID: 31765661
[TBL] [Abstract][Full Text] [Related]
35. Angelica tenuissima Nakai Ameliorates Cognitive Impairment and Promotes Neurogenesis in Mouse Model of Alzheimer's Disease.
Choi M; Lee Y; Cho SH
Chin J Integr Med; 2018 May; 24(5):378-384. PubMed ID: 28578486
[TBL] [Abstract][Full Text] [Related]
36. Propranolol reduces cognitive deficits, amyloid and tau pathology in Alzheimer's transgenic mice.
Dobarro M; Gerenu G; Ramírez MJ
Int J Neuropsychopharmacol; 2013 Nov; 16(10):2245-57. PubMed ID: 23768694
[TBL] [Abstract][Full Text] [Related]
37. Modulation of BDNF cleavage by plasminogen-activator inhibitor-1 contributes to Alzheimer's neuropathology and cognitive deficits.
Gerenu G; Martisova E; Ferrero H; Carracedo M; Rantamäki T; Ramirez MJ; Gil-Bea FJ
Biochim Biophys Acta Mol Basis Dis; 2017 Apr; 1863(4):991-1001. PubMed ID: 28132883
[TBL] [Abstract][Full Text] [Related]
38. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
[TBL] [Abstract][Full Text] [Related]
39. Deterioration of plasticity and metabolic homeostasis in the brain of the UCD-T2DM rat model of naturally occurring type-2 diabetes.
Agrawal R; Zhuang Y; Cummings BP; Stanhope KL; Graham JL; Havel PJ; Gomez-Pinilla F
Biochim Biophys Acta; 2014 Sep; 1842(9):1313-23. PubMed ID: 24840661
[TBL] [Abstract][Full Text] [Related]
40. Linagliptin, a Dipeptidyl Peptidase-4 Inhibitor, Mitigates Cognitive Deficits and Pathology in the 3xTg-AD Mouse Model of Alzheimer's Disease.
Kosaraju J; Holsinger RMD; Guo L; Tam KY
Mol Neurobiol; 2017 Oct; 54(8):6074-6084. PubMed ID: 27699599
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
